2019 Q4 Form 10-K Financial Statement
#000117184320001536 Filed on March 06, 2020
Income Statement
| Concept | 2019 Q4 | 2018 Q4 | 2018 Q3 |
|---|---|---|---|
| Revenue | $29.77M | $26.96M | $26.79M |
| YoY Change | 10.45% | -8.28% | -1.46% |
| Cost Of Revenue | $8.649M | $7.001M | $8.282M |
| YoY Change | 23.54% | -19.68% | 32.51% |
| Gross Profit | $21.12M | $19.95M | $18.50M |
| YoY Change | 5.89% | -1.09% | -11.61% |
| Gross Profit Margin | 70.95% | 74.01% | 69.06% |
| Selling, General & Admin | $12.24M | $6.130M | $5.700M |
| YoY Change | 99.67% | -8.23% | 18.18% |
| % of Gross Profit | 57.95% | 30.73% | 30.81% |
| Research & Development | $4.080M | $4.060M | $4.232M |
| YoY Change | 0.49% | -4.92% | -27.56% |
| % of Gross Profit | 19.32% | 20.35% | 22.88% |
| Depreciation & Amortization | $1.530M | $1.480M | $1.510M |
| YoY Change | 3.38% | 38.32% | 25.83% |
| % of Gross Profit | 7.24% | 7.42% | 8.16% |
| Operating Expenses | $16.32M | $10.19M | $9.932M |
| YoY Change | 60.16% | -6.86% | -6.87% |
| Operating Profit | $4.803M | $9.759M | $8.573M |
| YoY Change | -50.78% | 5.75% | -16.52% |
| Interest Expense | $360.0K | $550.0K | $522.0K |
| YoY Change | -34.55% | 292.86% | 100.0% |
| % of Operating Profit | 7.5% | 5.64% | 6.09% |
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | $5.160M | $10.31M | $9.095M |
| YoY Change | -49.95% | 4.46% | -13.63% |
| Income Tax | $1.110M | $2.600M | $1.496M |
| % Of Pretax Income | 21.51% | 25.22% | 16.45% |
| Net Earnings | $4.051M | $7.717M | $7.599M |
| YoY Change | -47.51% | -4.34% | 10.34% |
| Net Earnings / Revenue | 13.61% | 28.63% | 28.37% |
| Basic Earnings Per Share | $0.28 | $0.54 | $0.53 |
| Diluted Earnings Per Share | $0.28 | $0.54 | $0.53 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 14.27M | 14.24M | |
| Diluted Shares Outstanding | 14.62M | 14.30M | 14.38M |
Balance Sheet
| Concept | 2019 Q4 | 2018 Q4 | 2018 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $184.9M | $159.0M | $149.0M |
| YoY Change | 16.29% | 1.08% | -2.42% |
| Cash & Equivalents | $157.5M | $89.04M | $81.83M |
| Short-Term Investments | $27.50M | $70.00M | $67.20M |
| Other Short-Term Assets | $4.300M | $1.900M | $2.000M |
| YoY Change | 126.32% | -40.63% | -13.04% |
| Inventory | $22.00M | $21.30M | $23.83M |
| Prepaid Expenses | |||
| Receivables | $23.08M | $20.78M | $20.77M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $234.3M | $202.9M | $195.6M |
| YoY Change | 15.45% | -1.64% | -1.73% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $50.78M | $54.11M | $55.04M |
| YoY Change | -6.15% | -3.69% | 1.98% |
| Goodwill | $7.694M | $7.851M | $7.959M |
| YoY Change | -2.0% | -4.47% | -1.79% |
| Intangibles | $7.585M | $9.191M | $9.564M |
| YoY Change | -17.47% | -13.58% | -10.93% |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $7.478M | $4.897M | $1.109M |
| YoY Change | 52.71% | 290.51% | -13.56% |
| Total Long-Term Assets | $96.40M | $76.05M | $73.67M |
| YoY Change | 26.76% | -0.31% | -0.57% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $234.3M | $202.9M | $195.6M |
| Total Long-Term Assets | $96.40M | $76.05M | $73.67M |
| Total Assets | $330.7M | $279.0M | $269.3M |
| YoY Change | 18.54% | -1.28% | -1.42% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.832M | $3.143M | $2.462M |
| YoY Change | 21.92% | -53.42% | -52.55% |
| Accrued Expenses | $12.40M | $8.100M | $6.800M |
| YoY Change | 53.09% | 28.04% | 4.36% |
| Deferred Revenue | $52.00K | ||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $16.28M | $11.29M | $9.305M |
| YoY Change | 44.18% | -13.65% | -20.5% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $357.0K | $550.0K | $574.0K |
| YoY Change | -35.09% | -16.67% | 5.32% |
| Total Long-Term Liabilities | $357.0K | $550.0K | $574.0K |
| YoY Change | -35.09% | -16.67% | 5.32% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $16.28M | $11.29M | $9.305M |
| Total Long-Term Liabilities | $357.0K | $550.0K | $574.0K |
| Total Liabilities | $16.63M | $11.84M | $9.879M |
| YoY Change | 40.5% | -13.79% | -19.36% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $245.4M | $218.2M | $210.5M |
| YoY Change | 12.46% | 9.38% | 9.96% |
| Common Stock | $48.85M | $50.91M | $49.98M |
| YoY Change | -4.04% | -25.97% | -25.29% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $288.4M | $263.6M | $255.3M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $330.7M | $279.0M | $269.3M |
| YoY Change | 18.54% | -1.28% | -1.42% |
Cashflow Statement
| Concept | 2019 Q4 | 2018 Q4 | 2018 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $4.051M | $7.717M | $7.599M |
| YoY Change | -47.51% | -4.34% | 10.34% |
| Depreciation, Depletion And Amortization | $1.530M | $1.480M | $1.510M |
| YoY Change | 3.38% | 38.32% | 25.83% |
| Cash From Operating Activities | $13.03M | $10.01M | $10.85M |
| YoY Change | 30.17% | 43.41% | -10.33% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$270.0K | -$170.0K | -$1.210M |
| YoY Change | 58.82% | -93.12% | -53.28% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $41.29M | -$2.420M | -$53.93M |
| YoY Change | -1806.2% | -238.29% | 7090.67% |
| Cash From Investing Activities | $41.02M | -$2.580M | -$55.15M |
| YoY Change | -1689.92% | 258.33% | 1551.2% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 280.0K | -50.00K | 0.000 |
| YoY Change | -660.0% | -100.0% | |
| NET CHANGE | |||
| Cash From Operating Activities | 13.03M | 10.01M | 10.85M |
| Cash From Investing Activities | 41.02M | -2.580M | -55.15M |
| Cash From Financing Activities | 280.0K | -50.00K | 0.000 |
| Net Change In Cash | 54.33M | 7.380M | -44.30M |
| YoY Change | 636.18% | 17.89% | -600.0% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $13.03M | $10.01M | $10.85M |
| Capital Expenditures | -$270.0K | -$170.0K | -$1.210M |
| Free Cash Flow | $13.30M | $10.18M | $12.06M |
| YoY Change | 30.65% | 7.72% | -17.9% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q4 | anik |
Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
|
788000 | |
| CY2018Q4 | anik |
Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
|
577000 | |
| CY2019Q4 | anik |
Accrued Research Grants Current
AccruedResearchGrantsCurrent
|
393000 | |
| CY2018Q4 | anik |
Accrued Research Grants Current
AccruedResearchGrantsCurrent
|
400000 | |
| CY2019Q4 | anik |
Accumulated Currency Translation Adjustment
AccumulatedCurrencyTranslationAdjustment
|
-4759000 | |
| CY2018Q4 | anik |
Accumulated Currency Translation Adjustment
AccumulatedCurrencyTranslationAdjustment
|
-4576000 | |
| CY2019 | anik |
Allowance For Doubtful Accounts Receivable Translation Adjustments
AllowanceForDoubtfulAccountsReceivableTranslationAdjustments
|
-31000 | |
| CY2018 | anik |
Allowance For Doubtful Accounts Receivable Translation Adjustments
AllowanceForDoubtfulAccountsReceivableTranslationAdjustments
|
-86000 | |
| CY2017 | anik |
Allowance For Doubtful Accounts Receivable Translation Adjustments
AllowanceForDoubtfulAccountsReceivableTranslationAdjustments
|
117000 | |
| CY2019 | anik |
Deferred Income Tax Expense Benefit Foreign And Domestic Net
DeferredIncomeTaxExpenseBenefitForeignAndDomesticNet
|
597000 | |
| CY2018 | anik |
Deferred Income Tax Expense Benefit Foreign And Domestic Net
DeferredIncomeTaxExpenseBenefitForeignAndDomesticNet
|
-2347000 | |
| CY2017 | anik |
Deferred Income Tax Expense Benefit Foreign And Domestic Net
DeferredIncomeTaxExpenseBenefitForeignAndDomesticNet
|
-990000 | |
| CY2019Q4 | anik |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
5206000 | |
| CY2018Q4 | anik |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
||
| CY2019Q4 | anik |
Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
|
5171000 | |
| CY2018Q4 | anik |
Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
|
||
| CY2018 | anik |
Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
|
800000 | |
| CY2017 | anik |
Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
|
600000 | |
| CY2019 | anik |
Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeduction
|
-0.009 | |
| CY2018 | anik |
Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeduction
|
-0.013 | |
| CY2017 | anik |
Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeduction
|
0 | |
| CY2019 | anik |
Effective Income Tax Rate Reconciliation Section162 M Limitation
EffectiveIncomeTaxRateReconciliationSection162MLimitation
|
0.003 | |
| CY2018 | anik |
Effective Income Tax Rate Reconciliation Section162 M Limitation
EffectiveIncomeTaxRateReconciliationSection162MLimitation
|
0.043 | |
| CY2017 | anik |
Effective Income Tax Rate Reconciliation Section162 M Limitation
EffectiveIncomeTaxRateReconciliationSection162MLimitation
|
0.007 | |
| CY2019 | anik |
Effective Income Tax Reconciliation Nondeductible Expenses Permanent Items Percent
EffectiveIncomeTaxReconciliationNondeductibleExpensesPermanentItemsPercent
|
-0.001 | |
| CY2018 | anik |
Effective Income Tax Reconciliation Nondeductible Expenses Permanent Items Percent
EffectiveIncomeTaxReconciliationNondeductibleExpensesPermanentItemsPercent
|
-0.014 | |
| CY2017 | anik |
Effective Income Tax Reconciliation Nondeductible Expenses Permanent Items Percent
EffectiveIncomeTaxReconciliationNondeductibleExpensesPermanentItemsPercent
|
0.001 | |
| CY2019 | anik |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-1065000 | |
| CY2018 | anik |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
||
| CY2017 | anik |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
||
| CY2019Q4 | anik |
Inventory Raw Materials Work In Process And Finished Goods Net Of Reserve Total
InventoryRawMaterialsWorkInProcessAndFinishedGoodsNetOfReserveTotal
|
29165000 | |
| CY2018Q4 | anik |
Inventory Raw Materials Work In Process And Finished Goods Net Of Reserve Total
InventoryRawMaterialsWorkInProcessAndFinishedGoodsNetOfReserveTotal
|
25133000 | |
| CY2019Q4 | anik |
Inventory Recall Reserve
InventoryRecallReserve
|
0 | |
| CY2018Q4 | anik |
Inventory Recall Reserve
InventoryRecallReserve
|
0 | |
| CY2019 | anik |
Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
|
1179000 | |
| CY2018 | anik |
Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
|
||
| CY2017 | anik |
Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
|
||
| CY2018Q4 | anik |
Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
|
897000 | |
| CY2019 | anik |
Percentage Of Net Revenue
PercentageOfNetRevenue
|
1 | |
| CY2018 | anik |
Percentage Of Net Revenue
PercentageOfNetRevenue
|
1 | |
| CY2017 | anik |
Percentage Of Net Revenue
PercentageOfNetRevenue
|
1 | |
| CY2019 | anik |
Schedule Of Sharebased Compensation Exercisable Stock Options And Stock Appreciation Rights Award Activity Table Text Bloc
ScheduleOfSharebasedCompensationExercisableStockOptionsAndStockAppreciationRightsAwardActivityTableTextBloc
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number<br /> Outstanding</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Avg <br /> Exercise Price</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average <br /> Remaining Term<br /> (in years)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Incentive stock options</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 12%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,871</div></td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22.90</div></td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 12%; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.7</div></td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-qualified stock options</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">158,601</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38.82</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.8</div></td> <td style="white-space: nowrap; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Performance awards</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,269</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46.51</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.6</div></td> <td style="white-space: nowrap; text-align: left"> </td> </tr> </table></div> | |
| CY2019 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
|
8500000 | |
| CY2018 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
|
8500000 | |
| CY2017 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
|
500000 | |
| CY2019 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm
|
P5Y | |
| CY2018Q4 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice
|
42.06 | |
| CY2019Q4 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice
|
41.65 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercises In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriod
|
554241 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice
|
40.37 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Expirations In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExpirationsInPeriod
|
48647 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Expirations In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExpirationsInPeriodWeightedAverageExercisePrice
|
51.18 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeitures In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresInPeriod
|
97575 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeitures In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresInPeriodWeightedAverageExercisePrice
|
48.40 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Grants In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod
|
254517 | |
| CY2019 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Grants In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice
|
41.92 | |
| CY2018Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Number
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
|
1136914 | |
| CY2019Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Number
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
|
690968 | |
| CY2019Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
41.65 | |
| CY2019Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Ppreciation Rights Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockPpreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
8600000 | |
| CY2019 | anik |
Shares Issued Share Sharebased Payment Arrangement Nonoption Equity Instruments Exercised
SharesIssuedShareSharebasedPaymentArrangementNonoptionEquityInstrumentsExercised
|
31541 | |
| CY2019 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2019 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2019 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2019 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | |
| CY2019 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2019-12-31 | |
| CY2019 | dei |
Document Type
DocumentType
|
10-K | |
| CY2019 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000898437 | |
| CY2020Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
14168080 | |
| CY2019 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2019 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2019 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2019 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2019Q2 | dei |
Entity Public Float
EntityPublicFloat
|
570291558 | |
| CY2019 | dei |
Entity Registrant Name
EntityRegistrantName
|
Anika Therapeutics, Inc. | |
| CY2019 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2019 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
| CY2019 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2019 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2019 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.01 per share | |
| CY2019 | dei |
Trading Symbol
TradingSymbol
|
anik | |
| CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3832000 | |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3143000 | |
| CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
23079000 | |
| CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
20775000 | |
| CY2019Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
||
| CY2018Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
385000 | |
| CY2019Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
12445000 | |
| CY2018Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
8146000 | |
| CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
3850000 | |
| CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1989000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
28510000 | |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
24070000 | |
| CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-5898000 | |
| CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-5526000 | |
| CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
48707000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
50763000 | |
| CY2018 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1791000 | |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
89042000 | |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
133256000 | |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
104261000 | |
| CY2019 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
68421000 | |
| CY2018 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-44214000 | |
| CY2019 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
293000 | |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5807000 | |
| CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11046000 | |
| CY2019 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6087000 | |
| CY2019 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6087000 | |
| CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
11046000 | |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5807000 | |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1525000 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1914000 | |
| CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
194000 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
962000 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
962000 | |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1525000 | |
| CY2019 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
505000 | |
| CY2018 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
360000 | |
| CY2017 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
||
| CY2019 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
33000 | |
| CY2018 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
||
| CY2017 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
6000 | |
| CY2018 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1000000 | |
| CY2019 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1000000 | |
| CY2017 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1000000 | |
| CY2019Q4 | us-gaap |
Assets
Assets
|
330710000 | |
| CY2018Q4 | us-gaap |
Assets
Assets
|
278993000 | |
| CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
234306000 | |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
202943000 | |
| CY2019 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
137000 | |
| CY2018 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
351000 | |
| CY2017 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1891000 | |
| CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
157463000 | |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
28995000 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
90000000 | |
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
90000000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14308000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14210000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14308000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14210000 | |
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
143000 | |
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
142000 | |
| CY2019 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
26821000 | |
| CY2018 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
17980000 | |
| CY2017 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
34349000 | |
| CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-426000 | |
| CY2019 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-813000 | |
| CY2018 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-1203000 | |
| CY2017 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-496000 | |
| CY2019 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
794000 | |
| CY2019 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Concentration of Credit Risk and Significant Customers</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> significant off-balance sheet risks related to foreign exchange contracts, option contracts, or other foreign hedging arrangements. The Company’s cash equivalents and investments are held with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major international financial institutions.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company, by policy, routinely assesses the financial strength of its customers. As a result, the Company believes that its accounts receivable credit risk exposure is limited.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> Mitek represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%,</div> respectively, of the Company’s accounts receivable balance, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other single customer accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of accounts receivable in either period.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> | |
| CY2018Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
0 | |
| CY2019 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
28747000 | |
| CY2018 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
31280000 | |
| CY2017 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
27364000 | |
| CY2019Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8649000 | |
| CY2019Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
5951000 | |
| CY2019Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6836000 | |
| CY2019Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
7311000 | |
| CY2018Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
7001000 | |
| CY2018Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8282000 | |
| CY2018Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8152000 | |
| CY2018Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
7845000 | |
| CY2019 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
80362000 | |
| CY2018 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
83806000 | |
| CY2017 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
67691000 | |
| CY2019Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
0 | |
| CY2017Q4 | us-gaap |
Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
|
248000 | |
| CY2019 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
6245000 | |
| CY2018 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
4783000 | |
| CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
12608000 | |
| CY2019 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
202000 | |
| CY2018 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
405000 | |
| CY2017 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
31000 | |
| CY2019 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
8331000 | |
| CY2018 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
6832000 | |
| CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
15376000 | |
| CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1884000 | |
| CY2018 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1644000 | |
| CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2737000 | |
| CY2018 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1817000 | |
| CY2019 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
1086000 | |
| CY2018 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-992000 | |
| CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1198000 | |
| CY2019Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
15859000 | |
| CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
10753000 | |
| CY2019Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
4331000 | |
| CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
3542000 | |
| CY2019 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
324000 | |
| CY2018 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-152000 | |
| CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-68000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11528000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7211000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1187000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1500000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
1812000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
1382000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1901000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
3148000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
1076000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
818000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
|
346000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
|
363000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
|
2023000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
|
2405000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
8665000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
8348000 | |
| CY2019 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.05 | |
| CY2019 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
1.4 | |
| CY2019 | us-gaap |
Depreciation
Depreciation
|
5000000 | |
| CY2018 | us-gaap |
Depreciation
Depreciation
|
4900000 | |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
3300000 | |
| CY2019 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
5991000 | |
| CY2018 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
5910000 | |
| CY2017 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4290000 | |
| CY2019 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.93 | |
| CY2018 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.30 | |
| CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.18 | |
| CY2019Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.28 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.65 | |
| CY2019Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.68 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.32 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.54 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.53 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.69 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
| CY2019 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.89 | |
| CY2018 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.27 | |
| CY2017 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.11 | |
| CY2019Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.28 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.66 | |
| CY2019Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.67 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.31 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.54 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.53 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.68 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
| CY2019 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-133000 | |
| CY2018 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
29000 | |
| CY2017 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
349000 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.247 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.193 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.311 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.049 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0.028 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.002 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.004 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.005 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
0.006 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
-0.048 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
-0.002 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.055 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.055 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.048 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
|
0.001 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
|
0.002 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
|
0.007 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.014 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.034 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.014 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
5830000 | |
| CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4446000 | |
| CY2019 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
100000 | |
| CY2018 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
1500000 | |
| CY2017 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
400000 | |
| CY2017 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
700000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
15473000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
14439000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
900000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
1000000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
900000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
900000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
900000 | |
| CY2019Q4 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-300000 | |
| CY2018 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-400000 | |
| CY2019 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
25000 | |
| CY2018 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
371000 | |
| CY2017 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
||
| CY2019 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-927000 | |
| CY2018 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-152000 | |
| CY2017 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-150000 | |
| CY2019Q4 | us-gaap |
Goodwill
Goodwill
|
7694000 | |
| CY2018Q4 | us-gaap |
Goodwill
Goodwill
|
7851000 | |
| CY2017Q4 | us-gaap |
Goodwill
Goodwill
|
8218000 | |
| CY2019 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-157000 | |
| CY2018 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-367000 | |
| CY2019Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | |
| CY2019Q4 | us-gaap |
Gross Profit
GrossProfit
|
21118000 | |
| CY2019Q3 | us-gaap |
Gross Profit
GrossProfit
|
23664000 | |
| CY2019Q2 | us-gaap |
Gross Profit
GrossProfit
|
23577000 | |
| CY2019Q1 | us-gaap |
Gross Profit
GrossProfit
|
17406000 | |
| CY2018Q4 | us-gaap |
Gross Profit
GrossProfit
|
19949000 | |
| CY2018Q3 | us-gaap |
Gross Profit
GrossProfit
|
18499000 | |
| CY2018Q2 | us-gaap |
Gross Profit
GrossProfit
|
22390000 | |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
13413000 | |
| CY2019 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
389000 | |
| CY2018 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
||
| CY2017 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
||
| CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
38299000 | |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
26227000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
48446000 | |
| CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
36121000 | |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
23207000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
46202000 | |
| CY2019 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-2178000 | |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-3020000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-2244000 | |
| CY2019 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8928000 | |
| CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4485000 | |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14386000 | |
| CY2019 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
9257000 | |
| CY2018 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
5560000 | |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
15088000 | |
| CY2018Q1 | us-gaap |
Inventory Recall Expense
InventoryRecallExpense
|
1100000 | |
| CY2017 | us-gaap |
Inventory Recall Expense
InventoryRecallExpense
|
900000 | |
| CY2019Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
3000000 | |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6521000 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
767000 | |
| CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1671000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3890000 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1839000 | |
| CY2018 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2914000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2674000 | |
| CY2019 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-1085000 | |
| CY2018 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
922000 | |
| CY2017 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
367000 | |
| CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
3805000 | |
| CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1313000 | |
| CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1313000 | |
| CY2019 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
5585000 | |
| CY2018 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
7577000 | |
| CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1641000 | |
| CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-899000 | |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1454000 | |
| CY2019Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
28206000 | |
| CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
7585000 | |
| CY2018Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
9191000 | |
| CY2019 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
1873000 | |
| CY2018 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
1458000 | |
| CY2017 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
473000 | |
| CY2019Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
8777000 | |
| CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
6819000 | |
| CY2019Q4 | us-gaap |
Inventory Net
InventoryNet
|
21995000 | |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
21300000 | |
| CY2019Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
7170000 | |
| CY2018Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
3833000 | |
| CY2019Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
12058000 | |
| CY2018Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
13688000 | |
| CY2018Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
3500000 | |
| CY2019Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
8330000 | |
| CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
4626000 | |
| CY2019 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1612000 | |
| CY2018 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
4419000 | |
| CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
695000 | |
| CY2019 | us-gaap |
Lease Cost
LeaseCost
|
2309000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
21374000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
2025000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
1924000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1965000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
1981000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2024000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
8785000 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
330710000 | |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
278993000 | |
| CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16277000 | |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11289000 | |
| CY2019Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
27480000 | |
| CY2018Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
69972000 | |
| CY2019 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Nature of Business</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Anika Therapeutics, Inc. (the “Company”) is a global, integrated joint preservation and regenerative therapies company based in Bedford, Massachusetts. The Company aims to be the global leader in its space with innovative technologies that exceed its customers’ expectations. The Company is committed to delivering therapies to improve the lives of patients across a continuum of care from joint pain management therapies to orthopedic joint preservation and restoration. The Company has nearly <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty</div> years of global expertise commercializing more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twenty</div> products based on its hyaluronic acid, or HA, technology platform, and the Company is focused on adding innovative and differentiated offerings to its portfolio. The Company’s proprietary technologies for modifying the HA molecule allow product properties to be tailored specifically to therapeutic use. The Company’s patented technology chemically modifies HA to allow for longer residence time in the body. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> forms of cross-linked HA gel technologies, and a solid form of HA technology – HYAFF which is the platform for our regenerative medicine. These proprietary technologies are protected by an extensive portfolio of owned and licensed patents.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In early <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> the Company expanded its overall technology platform through its strategic acquisitions of Parcus Medical, LLC (“Parcus Medical”), a sports medicine implant and instrumentation solutions provider focused on surgical repair and reconstruction of ligaments and tendons and Arthrosurface, Incorporated (“Arthrosurface”) a joint preservation technology company specializing in less invasive joint replacement solutions. The Company expects the Parcus Medical and Arthrosurface acquisitions to drive growth by broadening Anika's product portfolio into joint preservation and restoration, adding high-growth revenue streams, expanding its commercial capabilities, diversifying its revenue base, and expanding its product pipeline and research and development expertise.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is subject to risks common to companies in the biotechnology and medical device industries including, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, commercialization of existing and new products, and compliance with U.S. Food and Drug Administration (“FDA”) and foreign regulations and approval requirements, as well as the ability to grow the Company’s business through appropriate commercial strategies.</div></div> | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-8142000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-28904000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
314000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
39691000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-50257000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-12480000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
37005000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
34918000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
40812000 | |
| CY2019 | us-gaap |
Net Income Loss
NetIncomeLoss
|
27193000 | |
| CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
18722000 | |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
31816000 | |
| CY2019Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4051000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9200000 | |
| CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9435000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4507000 | |
| CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7717000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7599000 | |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
10092000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6686000 | |
| CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
21749000 | |
| CY2019 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2019 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2019 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
34248000 | |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
45729000 | |
| CY2019 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
2087000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
21367000 | |
| CY2018Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
||
| CY2019 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1980000 | |
| CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
22864000 | |
| CY2018Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
||
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.041 | |
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P16Y292D | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
8703000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1879000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
414000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
1672000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
1924000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
1917000 | |
| CY2019Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
7500000 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
443000 | |
| CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
349000 | |
| CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
7478000 | |
| CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4897000 | |
| CY2019 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-372000 | |
| CY2018 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-742000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2533000 | |
| CY2019 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-400000 | |
| CY2018 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-700000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
2500000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
2533000 | |
| CY2018 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-742000 | |
| CY2019 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-372000 | |
| CY2019Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
357000 | |
| CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
550000 | |
| CY2019 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
30000000 | |
| CY2018 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
30000000 | |
| CY2017 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
||
| CY2019 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
293000 | |
| CY2018 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1790000 | |
| CY2017 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
||
| CY2019 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
103848000 | |
| CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4656000 | |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8980000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2018 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
91601000 | |
| CY2017 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
45000000 | |
| CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2827000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1250000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1250000 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4289000 | |
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1854000 | |
| CY2019 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
146366000 | |
| CY2018 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
46000000 | |
| CY2017 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
41500000 | |
| CY2019 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
22151000 | |
| CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2886000 | |
| CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
314000 | |
| CY2019Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
0 | |
| CY2018Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
0 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
79293000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
78181000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
50783000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
54111000 | |
| CY2017 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1609000 | |
| CY2019 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16665000 | |
| CY2019 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-499000 | |
| CY2018 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
57000 | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
16.87 | |
| CY2019 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
6000 | |
| CY2019 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
||
| CY2018Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26956000 | |
| CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18190000 | |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18787000 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
245426000 | |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
218233000 | |
| CY2019 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
114610000 | |
| CY2018 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
105555000 | |
| CY2017 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
113420000 | |
| CY2019Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
29772000 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
29697000 | |
| CY2019Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
30418000 | |
| CY2019Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
24723000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26787000 | |
| CY2018Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
30548000 | |
| CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
21264000 | |
| CY2019 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
24110000 | |
| CY2018 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
||
| CY2017 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
||
| CY2019 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in; text-indent: -0.55in"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> | |
| CY2019 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
216000 | |
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P3Y182D | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | |
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
14.73 | |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
20.01 | |
| CY2019 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
22151000 | |
| CY2019Q2 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
50000000 | |
| CY2019 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
253000 | |
| CY2018 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
247000 | |
| CY2017 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
493000 | |
| CY2019 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14374000 | |
| CY2018 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14689000 | |
| CY2019 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
34950000 | |
| CY2018 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
34336000 | |
| CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
21540000 | |
| CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6087000 | |
| CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11046000 | |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5807000 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2017 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
314000 | |
| CY2018 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2886000 | |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15068000 | |
| CY2019Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14621000 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14387000 | |
| CY2018 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
30000000 | |
| CY2019 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
30000000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
288378000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
263612000 | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
222773000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
263491000 | |
| CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2019Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14088000 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14314000 | |
| CY2018Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14299000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14377000 | |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14915000 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14679000 | |
| CY2019Q4 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14280000 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14070000 | |
| CY2019Q2 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
13916000 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14185000 | |
| CY2018Q4 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14168000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14237000 | |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14652000 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14679000 | |
| CY2019 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14121000 | |
| CY2018 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14442000 | |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14575000 |
